Lv2
150 积分 2025-06-11 加入
Advancements in delivery Systems for Proteolysis-Targeting Chimeras (PROTACs): Overcoming challenges and expanding biomedical applications
13天前
已完结
Liposomes-mediated enhanced antitumor effect of docetaxel with BRD4-PROTAC as synergist for breast cancer chemotherapy/immunotherapy
13天前
已完结
PROTAC Enabling Formulation In Vivo: Implications of the Polymeric Carrier Eudragit E PO
13天前
已完结
Developing Multi-Component Solid Formulation Strategies for PROTAC Dissolution Enhancement
13天前
已完结
Preparation and characterization of ASDs improves the solubility and dissolution performance of a PROTAC drug
13天前
已完结
Effect of Polymer Architecture and Acidic Group Density on the Degree of Salt Formation in Amorphous Solid Dispersions
23天前
已完结
Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023
24天前
已完结
Interplay of Drug–Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions
1个月前
已完结
Solubility Enhanced Formulation Approaches to Overcome Oral Delivery Obstacles of PROTACs
1个月前
已完结
Current advances and development strategies of orally bioavailable PROTACs
1个月前
已完结
皖公网安备34019202002308
